KJHP
ARLZ

K.J. Harrison & Partners’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

K.J. Harrison & Partners’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,000
Closed -$66K – 236
2016
Q2 		$66K Hold
20,000
– – 0.04% 163
2016
Q1 		$71K Buy
+20,000
New +$103K 0.04% 154

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TLCM
Tiger Legatus Capital Management New York $62.4M AUM 24.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CAD
Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

K.J. Harrison & Partners's ARLZ Position: Q3 2016 in Review

K.J. Harrison & Partners sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2016, closing a stake of 20,000 shares — an estimated $66K sold.

K.J. Harrison & Partners first reported a position in ARLZ in Q1 2016 and held it in 2 quarters. The position peaked at $71K in Q1 2016. 83 funds tracked by Wall St. Rank hold ARLZ as of Q3 2016.

  • K.J. Harrison & Partners reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
  • K.J. Harrison & Partners sold 20,000 Aralez Pharmaceuticals Inc. shares in Q3 2016, an estimated $66K.
  • K.J. Harrison & Partners first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 2 quarters.
  • K.J. Harrison & Partners's Aralez Pharmaceuticals Inc. position peaked at $71K in Q1 2016.
  • 83 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2016.

Based on K.J. Harrison & Partners's 13F filing for Q3 2016, filed 26 Oct 2016.